We treated DnaJC7 and DnaJB6 KO cell lines with either recombinant tau fibrils or brain lysates from subjects with Alzheimer’s Disease (AD), Progressive Supranuclear Palsy (PSP), or Corticobasal Degeneration (CBD). The gene discussed is MAPT; the disease is Alzheimer disease.